(Q30983599)

28 June 2017

title

Predicting the outcome of phase III trials using phase II data: a case study of clinical trial simulation in late stage drug development (English)

1 reference

28 June 2017

main subject

phase II clinical trial

0 references

phase III clinical trial

0 references

author name string

Filip De Ridder

series ordinal

1

1 reference

28 June 2017

language of work or name

1 reference

1 March 2005

1 reference

Basic and Clinical Pharmacology and Toxicology

28 June 2017

published in

1 reference

28 June 2017

volume

96

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

235-241

1 reference

Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960314.X

Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960314.X

The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960314.X

Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960314.X

Mixed-Effects Models in Sand S-PLUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960314.X

10.1111/J.1742-7843.2005.PTO960314.X

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference